ATRC vs CME · rev $294.9M vs P/E 22, rev $3.59B
AtriCure Inc (ATRC) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported ATRC revenue for 2026-06-30 was $294.9M. Net income was $9.1M. ATRC currently screens at market cap $1.37B.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
ATRC currently screens at market cap $1.37B. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the ATRC and CME stock pages for the full models.
Not investment advice.